PITX2 and neoplasm: However, a methylation-based CE-IVD marked assay, the Therascreen PITX2 RGQ PCR kit (Qiagen, Germany), which is designed to evaluate the methylation of the pituitary homeobox 2 (PITX2) gene in tumor biopsies, has been developed and commercialized.